Developing a Discrete Choice Experiment Instrument for Evaluating Patients' Preferences in Precision Oncology

Zahra Karimi Majd1, Nazila Yousefi1, Mohammad Peikanpour1

  • 1Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Summary

Patient preferences for precision oncology are crucial. A validated instrument identified key factors like treatment access, costs, life expectancy gains, and quality of life improvements for personalized medicine.